Approval · Notice of Compliance 5199 · 1995
ADALAT: Notice of Compliance 5199
Issued February 27, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5199
- Date
- February 27, 1995
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-anginal agent, antihypertensive agent, antianginal and anti-hypertensive agent
Products in this notice
Medicinal ingredients
- NIFEDIPINE 5 MG per CAP
- NIFEDIPINE 10 MG per CAP
- NIFEDIPINE 10 MG per TAB
- NIFEDIPINE 20 MG per TAB
- NIFEDIPINE 30 MG per TAB
- NIFEDIPINE 60 MG per TAB